DNM1L and Parkinson disease: Third, the ROCK1 activation inhibitor Y-27632 significantly improved symptoms in PD mice by inhibiting dephosphorylated Drp1, Drp1-mediated aberrant mitochondrial fission, and dopaminergic nerve cell apoptosis.